Your browser doesn't support javascript.
loading
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.
Olivo Pimentel, Veronica; Marcus, Damiënne; van der Wiel, Alexander Ma; Lieuwes, Natasja G; Biemans, Rianne; Lieverse, Relinde Iy; Neri, Dario; Theys, Jan; Yaromina, Ala; Dubois, Ludwig J; Lambin, Philippe.
Affiliation
  • Olivo Pimentel V; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • Marcus D; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • van der Wiel AM; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • Lieuwes NG; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • Biemans R; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • Lieverse RI; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • Neri D; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology, Zurich, Switzerland.
  • Theys J; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • Yaromina A; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
  • Dubois LJ; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands ludwig.dubois@maastrichtuniversity.nl.
  • Lambin P; The M-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University, Maastricht, The Netherlands.
J Immunother Cancer ; 9(3)2021 03.
Article in En | MEDLINE | ID: mdl-33688020
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Colonic Neoplasms / Carcinoma, Lewis Lung / B7-H1 Antigen / Chemoradiotherapy / Immune Checkpoint Inhibitors / Immunomodulating Agents / Lung Neoplasms Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Colonic Neoplasms / Carcinoma, Lewis Lung / B7-H1 Antigen / Chemoradiotherapy / Immune Checkpoint Inhibitors / Immunomodulating Agents / Lung Neoplasms Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom